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to 100 mg daily. After 13 days of treatment, she developed 
continuous visual illusions upon waking in the morn-
ing; when looking at human faces, they were distorted 
and swollen. On many occasions, objects in front of her 
appeared to be either nearer or farther away. These visu-
al phenomena persisted for approximately 12 hours and 
gradually disappeared with the discontinuation of topira-
mate. Thereafter, she never had similar experiences. None 
of these events was accompanied by the loss of conscious-
ness or headache. The patient’s impressions of reality and 
self-recognition were preserved. The neurological and psy-
chiatric examination was normal, and a complete exami-
nation by a neuro-ophthalmologist was normal. An EEG, 
with activation procedures (hyperventilation and photic 
stimulation), and the MRI of the brain were normal.
Metamorphopsia is a visual illusion affecting the perception 
of the size, shape or inclination of objects1. Although this condi-
tion occurs in migraine aura, topiramate has been reported to 
induce other visual illusions, such as palinopsia (the illusion of 
a persistent or recurrent visual images following the removal of 
the exciting stimulus)2 and alterations in body perception (“Alice 
in Wonderland syndrome”) in patients with migraines3.
The mechanism by which topiramate may cause these vi-
sual illusions in migraineurs is unknown. However, because it 
may occur in the aura of migraines, these visual illusions are 
likely to be a result of the migraine.
1. River Y, Ben Hur T, Steiner I. Reversal of vision metamorphopsia: clinical 
and anatomical characteristics. Arch Neurol 1998;55:1362-1368.
2. Evans RW. Reversible palinopsia and the Alice in Wonderland 
syndrome associated with topiramate use in migraineurs. Headache 
2006;46:815-818.
3. Jürgens TP, Ihle K, Stork JH, May A. “Alice in Wonderland 
syndrome” associated with topiramate for migraine prevention. 
J Neurol Neurosurg Psychiatry 2011;82:228-229. doi:10.1136/
jnnp.2009.187245
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The frontotemporal dementia (FTD) is the second 
most common form of dementia in patients younger than 
65 years, and its behavioral variant (bvFTD) is the most 
prevalent form1,2. During the last years, the overlapping 
between FTD and amyotrophic lateral sclerosis (ALS) has 
been frequently recognized, with symptoms of FTD pre-
ceding ALS and vice-versa. Herein, we report a case of 
ALS, which afterwards presented psychotic and behavioral 
symptoms, whose neuropathological diagnosis was com-
patible with bvFTD-ALS with TAR DNA-binding protein 43 
(TDP-43) inclusion3.
CaSE REpoRT
A 58-year-old man was admitted in our Emergency 
Unit with a one-year history of progressive weakness of 
limbs, associated with dysarthria, dysphonia, difficulty to 
close mouth and hands atrophy. Four days before admis-
sion, he developed dyspnea and acute respiratory failure. 
In the hospital, it was seen generalized weakness, glob-
al hyperreflexia, fasciculations on right arm, no sensory 
abnormalities, and the electroneuromyography showed 
chronic and acute denervation signs in cranial, cervical 
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and lumbosacral segments, confirming the diagnosis of 
amyotrophic lateral sclerosis. As the patient had no social 
and economic home support, he lived the rest of his life 
hospitalized, with mechanic ventilation. In the first year 
after admission, the patient showed anxious and depres-
sive symptoms, associated with a permanent refusal of his 
condition, with great hopes of cure, even after exhaustive 
explanation about the diagnosis. This behavior was con-
sidered as mechanism of denial.
Progressively, the patient became hostile to nurses and 
physicians, blaming his disease to clinical staff, with fre-
quent verbal aggression. He said that the family was vis-
iting him, but there were no proof of these visits. After 2 
years of hospitalization, the agressivity worsened, without 
improvement with antidepressants drugs. The patient af-
firmed that the disease could be resolved with antibiotic, 
but the physicians did not want to treat him. In his last 
months, the persecutory delusions became more intense, 
associated with visual hallucinations. As there were no 
clinical signs of delirium, a psychotic delusional disorder 
was diagnosed and neuroleptic medications were started. 
His psychiatric status progressively worsened, with audi-
tory hallucinations and physical aggression to the clinical 
staff. After 2 years and 9 months of hospitalization, the pa-
tient died by asphyxia by tracheal blood clot.
On necropsy (Fig), it was seen moderate reduction in 
hypoglossus nucleus and in anterior column of spinal cord 
motor neurons, and myelin pallor on anterior and lateral 
funiculi, sparing posterior funiculus (Fig C), and the brain 
showed spongiosis in layer II, predominantly in temporal 
cortex (Fig A and B). The immunoreactivity to protein tau 
was negative, but there were granular neuronal intracyto-
plasmatic inclusions and dystrophic neurites positive to 
ubiquitin and TDP-43 (subtype 3 from Mackenzie et al.)4. 
DiSCuSSion
The discovery of TDP-433-5 in brains of patients with 
the association FTD-ALS has improved the comprehen-
sion of its pathophysiology. This specific phenotype often 
shows the presence of delusions and hallucinations1, as 
seen in our case, and these symptoms should draw our 
attention to the possibility of TDP-43 proteinopathy on 
motor neuron disease. As the patient was hospitalized 
during almost 3 years, it was possible to register details 
of his behavioral degeneration.
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Fig. (A) Temporal cortex. Microvacuolization of layer II. Hematoxylin and Eosin, X100. (B) Frontal cortex. Neuronal intracytoplasmic 
inclusions (yellow arrows) and in dystrophic neurites (black arrows). Immunohistochemistry for TDP-43, X400. (C) Anterior horn of 
the spinal cord. Marked loss of motor neurons. Hematoxylin and Eosin, X100.
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